UiPath (PATH) Cpo & CTO Malpani Raghavendra Sells $399K of Stock

UiPath's Chief Technology Officer sold nearly 30,000 shares amid recent trading activity.

Reviewed by automated data checks against the source filing. How we make and check alerts

Malpani Raghavendra, CPO & CTO at UiPath, Inc. ($PATH), sold 29,564 shares at an average price of $13.51, worth about $399,264.78, on October 9, 2026. The trade was reported to the SEC in a Form 4 filing and was made under a pre-arranged Rule 10b5-1 trading plan.

Since the trade, $PATH is down 4.7% after 1 week and down 4.7% to date (from the $13.48 close on Oct 9, 2026).

Find the original: PATH Form 4 filings on SEC EDGAR

PATH UiPath, Inc.
$12.85 -19.08% year to date
Daily close · Oct 16, 2026

Key Points

  • On October 9, 2026, Malpani Raghavendra sold 29,564 shares of UiPath, Inc. for approximately $399,264.78 at a price of $13.51 each.
  • UiPath's stock recently traded around $12.85, which is about 12.7% below its 50-day moving average of $14.72.
  • The company has a market cap of about $7.15 billion and a trailing P/E ratio of 20.5.

Get $PATH trade alerts by text

We text you when insiders, Congress or big funds trade $PATH. Free.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated UiPath, Inc. alert may contain errors. Disclosures

Malpani Raghavendra, the Chief Technology Officer of UiPath, Inc. (NYSE: PATH), sold 29,564 shares on October 9, 2026. The total value of this sale was approximately $399,264.78, with shares sold at an average price of $13.51 each. This transaction was part of a planned selling strategy under a Rule 10b5-1 plan.

Other Institutional Activity in UiPath

Several other institutional investors have been active in UiPath recently. Blackrock Inc. grew its holdings by 3,095,820 shares, ending with 46,153,124 shares worth about $593.1 million. Tetragon Partners GP Ltd. added 5,742,312 shares, bringing its total to 30,950,000 shares valued at approximately $397.7 million. Vanguard Portfolio Management LLC slightly reduced its stake by 166,872 shares, ending with 26,320,700 shares worth about $338.2 million. Vanguard Capital Management LLC increased its position by 115,291 shares, totaling 18,710,688 shares valued at around $240.4 million. Two Sigma Investments, LP significantly boosted its holdings by 11,475,068 shares, resulting in a total of 15,034,443 shares worth about $193.2 million.

UiPath, Inc. Stock Down 1.6%

UiPath's shares recently traded around $12.85, which puts them about 12.7% below the 50-day moving average of $14.72. The stock is also about 35.2% below its 52-week high of $19.84 but 39.7% above its 52-week low of $9.20. The company's average target price is $15.50, suggesting that analysts see potential for upside from recent trading levels.

Recent Earnings

UiPath reported trailing twelve-month revenue of approximately $1.72 billion, which reflects a year-over-year growth of 13.4%. The company has an earnings per share (EPS) of $0.67 and a net margin of 21.0%. The next earnings report is scheduled for December 2, 2026.

Insider Buying and Selling at UiPath, Inc.

In addition to Raghavendra Malpani's recent sale, he sold 98,429 shares at $13.81 on September 16, 2026, and another 40,464 shares at $14.00 on September 17, 2026. Ashim A Gupta, the Chief Operating Officer, also sold 66,052 shares at $13.17 on October 2, 2026. These transactions indicate ongoing insider activity around the company's stock.

Analysts Set New Price Targets

On September 24, 2026, BMO Capital maintained its "Market Perform" rating with a price target of $15.00, down from $18.00. Canaccord Genuity also maintained a "Hold" rating with a new target of $14.00, reduced from $17.00. TD Cowen kept its "Hold" rating with a target of $15.00, down from $16.00. UBS maintained a "Neutral" rating with a target of $14.00, while DA Davidson downgraded the stock to "Underperform" with a target of $10.00.

About UiPath

UiPath, Inc. provides an automation platform that focuses on robotic process automation (RPA) solutions. The company primarily operates in the United States and several European countries. Its platform integrates AI agents and robots to enhance workflow efficiency, making it a key player in the automation software industry.

Bottom Line

Investors should monitor UiPath's performance closely, especially with the next earnings report set for December 2, 2026, and ongoing insider trading activity. Malpani's recent sale adds context to the current trading environment as the stock remains below its 50-day moving average and has seen mixed analyst ratings recently.

Source: Malpani Raghavendra's Form 4 filing on $PATH (Oct 9, 2026). Find the original filing: PATH Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts

Get $PATH trade alerts by text